CLOSE X

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE165.90-0.9 (-0.54 %)
PREV CLOSE ( ) 166.80
OPEN PRICE ( ) 164.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 78760
TODAY'S LOW / HIGH ( )162.95 167.20
52 WK LOW / HIGH ( )109.2 257.7
NSE165.90-1.04 (-0.62 %)
PREV CLOSE( ) 166.94
OPEN PRICE ( ) 165.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 165.90 (3926)
VOLUME 784168
TODAY'S LOW / HIGH( ) 162.80 167.28
52 WK LOW / HIGH ( )109.3 258
Select year
Particulars
Mar 2024
Mar 2023
Operational & Financial Ratios
 
 
   Earnings Per Share (Rs)
-11.93  
-6.86  
   CEPS(Rs)
-11.55  
-6.50  
   DPS(Rs)
0.00  
0.00  
   Book NAV/Share(Rs)
3.88  
15.80  
   Tax Rate(%)
-0.10  
0.00  
Margin Ratios
 
 
   Core EBITDA Margin(%)
-532.26  
-89.65  
   EBIT Margin(%)
-509.81  
-90.02  
   Pre Tax Margin(%)
-512.05  
-93.22  
   PAT Margin (%)
-512.56  
-93.22  
   Cash Profit Margin (%)
-496.00  
-88.29  
Performance Ratios
 
 
   ROA(%)
-57.63  
-26.81  
   ROE(%)
-121.28  
-43.41  
   ROCE(%)
-112.35  
-41.91  
   Asset Turnover(x)
0.11  
0.29  
   Sales/Fixed Asset(x)
0.50  
1.63  
   Working Capital/Sales(x)
17.46  
0.87  
Efficiency Ratios
 
 
   Fixed Capital/Sales(x)
2.01  
0.61  
   Receivable days
116.55  
50.01  
   Inventory Days
0.00  
0.00  
   Payable days
  
  
Valuation Parameters
 
 
   PER(x)
0.00  
0.00  
   PCE(x)
-32.04  
-27.62  
   Price/Book(x)
95.47  
11.36  
   Yield(%)
0.00  
0.00  
   EV/Net Sales(x)
157.49  
23.92  
   EV/Core EBITDA(x)
-31.93  
-28.11  
   EV/EBIT(x)
-30.89  
-26.57  
   EV/CE(x)
68.87  
11.14  
   M Cap / Sales
158.92  
24.39  
Growth Ratio
 
 
   Net Sales Growth(%)
-68.36  
0.00  
   Core EBITDA Growth(%)
-83.40  
0.00  
   EBIT Growth(%)
-79.18  
0.00  
   PAT Growth(%)
-73.96  
0.00  
   EPS Growth(%)
-73.96  
0.00  
Financial Stability Ratios
 
 
   Total Debt/Equity(x)
0.37  
0.00  
   Current Ratio(x)
1.02  
2.54  
   Quick Ratio(x)
1.02  
2.54  
   Interest Cover(x)
-227.27  
-28.15  
   Total Debt/Mcap(x)
0.00  
0.00  
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors